BioSpace News Archive

Drug Development

Akero’s NASH Candidate Clears Phase IIb, Cuts Liver Fat by up to 65%

Non-alcoholic steatohepatitis patients treated with the company’s efruxifermin saw significant improvements in liver fat and biomarkers of liver damage, fibrosis and cardiometabolic health.

June 5, 2023
·
4 min read
·
Tristan Manalac
Drug Development

ASCO: French Pharma’s Drug Slows Tumors in Brain Cancer Patients

Servier Pharmaceuticals’ Vorasidenib, acquired from Agios in a $1.8 billion deal, slowed the growth of a certain type of low-grade glioma by 61% in a Phase III trial.

June 5, 2023
·
3 min read
·
Heather McKenzie
Drug Development

ASCO: AstraZeneca Imfinzi-Lynparza Shows Benefit in Phase III Ovarian Cancer Study

The combination therapy was added to standard chemotherapy and lowered the risk of progression or death by 37% in newly diagnosed patients with advanced ovarian cancer without BRCA mutations.

June 5, 2023
·
2 min read
·
Lisa Munger
Drug Development

ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients

After five years of follow-up, AstraZeneca’s Tagrisso reduces the risk of death by 51% as compared with placebo in EGFR-mutated NSCLC patients, according to Phase III ADAURA trial results.

June 5, 2023
·
2 min read
·
Tristan Manalac
Drug Development

ASCO: BMS’ Opdivo Challenges Seagen’s Adcetris with Phase III Win

Data from a new head-to-head study showed BMS’ Opdivo induced better progression-free survival among Hodgkin’s lymphoma patients than Seagen’s Adcetris.

June 5, 2023
·
2 min read
·
Tristan Manalac
Genetown

ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes

ERYTECH Pharma announced that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the merger with Pherecydes at the Annual General Meeting on June 23.

June 5, 2023
·
1 min read
Drug Development

Transgene Presents Immunological Data Demonstrating that TG4001, a Novel Therapeutic Cancer Vaccine, Can Induce T-cell Responses Against HPV16 Antigens in the Ongoing Phase II Trial at ASCO 2023

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that new data will be presented on TG4001.

June 5, 2023
·
6 min read
Genetown

Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June

Biophytis SA announces it will participate at the Biotechnology Innovation Organization International Convention to be held in Boston from the 5th to the 8th of June 2023, alongside thousands of world leaders in biotechnology and the pharmaceutical industry.

June 5, 2023
·
3 min read
Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company’s Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

Gencurix, a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesWell BCT, with Oncotype DX, the globally top-selling test, confirming its outstanding performance.

June 5, 2023
·
4 min read
Business

ANGLE Announces Senior Management Appointments

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce the appointments of Brett Swansiger as Chief Commercial Officer and Karen Miller PhD as Chief Scientific Officer.

June 5, 2023
·
7 min read